Difficulty: Medium
Average Score: 78%
Practice
Among the rheumatoid arthritis disease-modifying drugs, fastest symptom relief is obtained with
Correct answer
D
Rationale
In the context of rheumatoid arthritis (RA) treatment, Methotrexate is considered the cornerstone disease-modifying antirheumatic drug (DMARD) due to its efficacy and safety profile. Methotrexate works by suppressing the immune system and reducing inflammation associated with RA, leading to symptom relief and slowing down disease progression. It is known for providing faster relief compared to other DMARDs like Auranofin, Penicillamine, and Sulfasalazine.
Auranofin is a gold-containing compound that is less commonly used today due to its side effects and less potent efficacy compared to Methotrexate. Penicillamine, an older DMARD, has been largely replaced by newer, more effective drugs like Methotrexate. Sulfasalazine, while effective for some RA patients, usually takes longer to show significant symptom improvement compared to Methotrexate.
Educationally, understanding the differences in onset of action and efficacy among DMARDs is crucial for healthcare professionals managing RA patients. Knowing that Methotrexate offers faster symptom relief can help guide treatment decisions and improve patient outcomes by initiating appropriate therapy promptly. It also underscores the importance of evidence-based practice in selecting the most suitable medications for RA management.
Auranofin is a gold-containing compound that is less commonly used today due to its side effects and less potent efficacy compared to Methotrexate. Penicillamine, an older DMARD, has been largely replaced by newer, more effective drugs like Methotrexate. Sulfasalazine, while effective for some RA patients, usually takes longer to show significant symptom improvement compared to Methotrexate.
Educationally, understanding the differences in onset of action and efficacy among DMARDs is crucial for healthcare professionals managing RA patients. Knowing that Methotrexate offers faster symptom relief can help guide treatment decisions and improve patient outcomes by initiating appropriate therapy promptly. It also underscores the importance of evidence-based practice in selecting the most suitable medications for RA management.